Tag Archives: IMROZ trial

Sarclisa Combination Treatment Shows Promise in Phase 3 Trial for Newly Diagnosed Multiple Myeloma Patients

Posted on 8, December 2023 by

(IN BRIEF) The Phase 3 IMROZ trial, assessing the use of Sarclisa® (isatuximab) in combination with standard-of-care bortezomib, lenalidomide, and dexamethasone (VRd), has achieved its primary efficacy endpoint at a planned interim analysis. The trial demonstrated a statistically significant improvement … Read the full press release →

Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology

Tagged , , , , ,